Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

TeliaSonera

TeliaSonera is the leading telecommunications company in the Nordic and Baltic region and also holds strong positions in mobile communications in Eurasia, Turkey and Russia. We offer reliable, innovative and easy-to-use services for the transmission and packaging of sound, images, data, information, transactions and entertainment. We see simplicity and service as important drivers for creating long-term growth and value for our customers and shareholders. On the home markets in the Nordic and Baltic regions, TeliaSonera has a wide range of services within mobile, fixed voice, data communications and broadband. TeliaSonera has strong or leading positions in all of these markets. The majority of TeliaSonera's operations on the home markets are wholly owned.The home markets are characterized by a high degree of maturity, high penetration and an increasing migration from fixed services to mobile and IP-based services. The overarching goal on the home markets is to create growth and maintain profitability. Within this framework, strategic prioritizations are made for each market and segment.


Contact Details:
P.O.Box 4700
Sonera
FIN-00051
Finland
Tel:358 800 188188
Fax:0800 188111
Email:yritysasiakaspalvelu@sonera.com
WWW:

www.telia.com/




Press Releases on TeliaSonera:

BioPortfolio Logo
Roshan Announces Expansion of Afghanistan's First Telemedicine Project to Bamyan Region 1st June, 2009 Roshan
Roshan, Cisco, the Government of Afghanistan, The Aga Khan University Hospital, Karachi, the French Medical Institute for Children, Aga Khan Health Services and the Bamyan Provincial Hospital Team up

BioNews Results for TeliaSonera:

FLASH: SkyePharma trading continues in line for FY
Business Financial Newswire:  Nov 12 2009 8:58AM Matching: teliasonera
FLASH: Hikma Pharmaceuticals full year sales up
Business Financial Newswire:  Nov 12 2009 8:57AM Matching: teliasonera

TeliaSonera Patents:

US Patent No.Title
7450957 System and method for blocking the use of a service in a telecommunication system
7221959 System and method for determining, storing and utilizing operating mode data of a user telecommunication terminal
7212543 Method, system and device for establishing communication between different communication networks
7139281 Method, system and router providing active queue management in packet transmission systems
7113800 Method and system for the routing of short messages

View more TeliaSonera patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 189 times since April 2007, the link to the organisation's website has been followed 35 times

Search for more companies in Sonera

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for TeliaSonera

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.